Drug makers may profit from disease in global warming scourge

on

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year – provided drug makers find innovative treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissions increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the report said.

Related Posts

on
Some MPs say the arrangement — which gives Turkish Petroleum 95% of revenues on estimated 20 billion barrels of oil — is "illegitimate".
on
Hundreds of representatives from the world’s most powerful industry bodies representing sectors that harm, or exploit, the natural world were present on the ground at the October nature summit in ...
on
TotalEnergies has won plaudits for voluntary steps to tackle the planet-heating gas. So why does it fund moves to delay, dilute or dismantle regulation?
on
Key piece of EU climate legislation facing coordinated pushback from TotalEnergies lobbyist and U.S. officials.